As a result of their partnership with The Chase Group, Genmab has secured a Director, Global Drug Safety and Pharmacovigilance Physician for their team in Copenhagen, Denmark. In this newly created position, the Drug Safety Physician will report to the Vice President, Head of Global Drug Safety, and serve as the safety expert accountable for the global safety strategy and overall safety profile for the assigned Genmab products throughout their lifecycle. A team player with infectious enthusiasm and passion to make a difference, this physician is a perfect fit, bringing a depth of drug safety, pharmacovigilance knowledge, and experience to Genmab’s team. The company has two approved antibodies and a robust clinical and pre-clinical pipeline. Their current trajectory is leading to exciting developments in the treatment of cancer and company growth. The Chase Group is proud to partner, identify, and secure the high caliber talent needed to revolutionize the treatment of cancer and improve the lives of patients around the world. For more information, please contact ken@chasegroup.com.
The Chase Group Secures Director of Drug Safety in Copenhagen/Denmark for Genmab
As a result of their partnership with The Chase Group, Genmab has secured a Director, Global Drug Safety and Pharmacovigilance Physician for their team in Copenhagen, Denmark. In this newly created position, the Drug Safety Physician will report to the Vice President, Head of Global Drug Safety, and serve as the safety expert accountable for the global safety strategy and overall safety profile for the assigned Genmab products throughout their lifecycle. A team player with infectious enthusiasm and passion to make a difference, this physician is a perfect fit, bringing a depth of drug safety, pharmacovigilance knowledge, and experience to Genmab’s team. The company has two approved antibodies and a robust clinical and pre-clinical pipeline. Their current trajectory is leading to exciting developments in the treatment of cancer and company growth. The Chase Group is proud to partner, identify, and secure the high caliber talent needed to revolutionize the treatment of cancer and improve the lives of patients around the world. For more information, please contact ken@chasegroup.com.
The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike…
Arcturus Therapeutics Secures Head of Drug Safety Through Continued Partnership with The Chase Group
The Chase Group’s track record for success continues with another executive placement secured for Arcturus Therapeutics. Entering a new stage in clinical development, Arcturus retained…
Leadership Team Grows at Biologics Consulting Through Partnership with The Chase Group
Biologics Consulting, currently experiencing a season of growth, retained The Chase to build out their leadership team. Tasked with identifying a Regulatory Project Management Lead,…-
The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience…. -
The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics
The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD as the Vice President, Pulmonary and Rare Diseases Clinical Development… 
Drug Safety Leadership Team Grows at Ionis Pharmaceuticals Through Continued Partnership with The Chase Group
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually…